Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 2

2(28.6%)

Phase 3

1(14.3%)

7Total

N/A(4)

Phase 2(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06265051Phase 2Completed

Tirofiban After Successful MT Recanalization in AIS

Role: collaborator

NCT07177807Completed

Clinical Characteristics of Neovascular Glaucoma

Role: collaborator

NCT06662643Not ApplicableActive Not Recruiting

A Clinical Trial Comparing Staged Turnbull-Cutait Pull-through Anastomosis With Direct Anastomosis Plus Prophylactic Ileostomy in the Treatment of Low Rectal Cancer After Internal Sphincter Resection

Role: collaborator

NCT06345365Phase 3Recruiting

MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

Role: collaborator

NCT05674214Completed

Birth Weight-discordance in Twins Pregnancy: a Multicenter Retrospective Study

Role: collaborator

NCT05621473Not ApplicableUnknown

Comparing the Safety and Effectiveness of Tunnel PICC Guided by EDUG and Conventional PICC

Role: collaborator

NCT05468177Phase 2Unknown

Cetuximab in Combination With Anti-PD-1 and mFOLFOX Treat For RAS/BRAF wt Right-Sided Colon Cancer

Role: collaborator

NCT03688828Not ApplicableCompleted

Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori

Role: collaborator

NCT05089500Not ApplicableUnknown

The Two Treatment Methods Compared the Sclerosing Agent Injection and the Rubber Wrapping

Role: collaborator

All 9 trials loaded